QualityStocks.net News – Aida Pharmaceuticals Inc. (AIDA.OB) Develops Wide-Spectrum Antibiotic

At www.QualityStocks.Net you can sign up for Quality Stock's Daily Newsletter to find out what Small-Cap and Micro-Cap online Investment Newsletters are interested in, plus hear about the latest news from our clients as well as other publicly traded companies.

We would like to highlight Aida Pharmaceuticals, Inc. (OTCBB: AIDA). The company is a product-focused pharmaceuticals company engaged in the formulation, clinical testing, registration, manufacture, sales and marketing of advanced pharmaceutical and genetic products in mainland China. The Company's mission is to discover, develop and market meaningful new therapies that improve human health.

In the Company’s news today,

Aida Pharmaceuticals Inc. (AIDA) announced its recently-acquired research institute, the Jiangsu Institute of Microbiology Co. Ltd, is working toward the development of a new wide-spectrum antibiotic, Wetimicin, in the People’s Republic of China. The company believes Wetimicin will have a larger market volume than its current product, Etimicin Sulphate.

Wetimicin is part of the amino-glycoside family of antibiotics, and is being tested for its efficacy in the treatment of inflammation stemming from respiratory infection, urogenital infection, soft skin tissue infection, as well as trauma from operations and more.

Wetimicin’s stronger applicability to such a wide range of ailments supports JSIM scientists’ belief that the product may be more reliable for children and elderly patients than other products on the market.

Aida Pharmaceuticals launched research for the drug in 2000, and is currently working through Phase 1 clinical trials in conjunction with the Chinese government’s State Food and Drug Administration. The company anticipates Phase 2 testing will start sometime this year. Once approved by China’s SFDA, the company will have the right of first refusal regarding the manufacturing and marketing of the drug.

About QualityStocks

QualityStocks.net, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks.net is dedicated to assisting emerging public companies with their advertising efforts and now has over 500,000+ subscribers that receive The Daily Stock Newsletters.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks.net website: http://Disclaimer.QualityStocks.net